Oral anticoagulants (OACs) are medications commonly used in patients with atrial fibrillation and other cardiovascular conditions. Both warfarin and direct oral anticoagulants are susceptible to ...

Jazz Pharmaceuticals Presents Late-Breaking Phase 4 Data Showcasing Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution Treatment Outcomes in Narcolepsy at SLEEP 2025 ...

The FDA has approved Khindivi (hydrocortisone) oral solution as a replacement therapy for children aged 5 years and older with adrenocortical insufficiency.This ready-to-use, berry-flavored liquid ...

Morphine: People can take morphine as an oral solution. It is often available in three concentrations: 2, 4, and 20 mg per milliliter. The recommended dosage to start treatment in adults is 10 to ...

The berry-flavored oral solution contains 1mg of hydrocortisone per mL and does not require refrigeration, mixing, or shaking. “For decades, patients have been seeking an FDA -approved hydrocortisone ...

Pfizer halted its oral obesity drug, danuglipron, in April 2025 due to liver injury concerns, a major pipeline setback. Find out why PFE stock is a Hold.

In TODAY.com's Expert Tip of the Day, a heart surgeon reveals the common oral hygiene product that may be hurting your cardiovascular health and what to use instead. IE 11 is not supported.

Eton Pharmaceuticals’ new drug application (NDA) for Khindivi, an oral solution of hydrocortisone, has received US Food and Drug Administration (FDA) approval as a replacement therapy for ...

Credit: Eton. Khindivi is expected to be available the week of June 2, 2025. Khindivi is the first FDA-approved hydrocortisone oral solution. The Food and Drug Administration (FDA) has approved ...

DEER PARK, Ill., May 28, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc ("Eton” or "the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing ...